Moreover, miRNA-148-3p targets SMAD2, resulting in the downregulation of the latter and tumor suppression [47], while miR-195 also suppresses HCC development via interacting with the G1-S cell cycle regulatory genes such as CDC25A, CDK6, CDK4, as well as CCNE1. This evidence concerns the gene SMAD2 and hepatocellular carcinoma.